Skip to Content

KU 210 (Montelukast Sodium 10 mg (base))

Pill with imprint KU 210 is White, Round and has been identified as Montelukast Sodium 10 mg (base). It is supplied by Kremers Urban Pharmaceuticals Inc..

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 210

Montelukast sodium 10 mg (base) KU 210
Montelukast sodium 10 mg (base) KU 210
Montelukast sodium 10 mg (base) KU 210

Montelukast Sodium

Imprint
KU 210
Strength
10 mg (base)
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Leukotriene modifiers
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Kremers Urban Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, hydroxypropyl cellulose (type h), mannitol, microcrystalline cellulose, polyethylene glycol, sodium stearyl fumarate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
62175-0210 Kremers Urban Pharmaceuticals Inc.
42291-0621 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.